nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorpromazine—ABCB1—esophageal cancer	0.336	1	CbGaD
Chlorpromazine—BCHE—Cisplatin—esophageal cancer	0.0312	0.577	CbGbCtD
Chlorpromazine—BCHE—diaphragm—esophageal cancer	0.0156	0.104	CbGeAlD
Chlorpromazine—HTR7—vagus nerve—esophageal cancer	0.0116	0.0775	CbGeAlD
Chlorpromazine—ALB—Methotrexate—esophageal cancer	0.00983	0.182	CbGbCtD
Chlorpromazine—ABCB1—Cisplatin—esophageal cancer	0.00792	0.146	CbGbCtD
Chlorpromazine—HTR2A—vagus nerve—esophageal cancer	0.00725	0.0484	CbGeAlD
Chlorpromazine—ABCB1—Methotrexate—esophageal cancer	0.00514	0.095	CbGbCtD
Chlorpromazine—CHRM3—exocrine gland—esophageal cancer	0.00419	0.0279	CbGeAlD
Chlorpromazine—CALM2—exocrine gland—esophageal cancer	0.0041	0.0274	CbGeAlD
Chlorpromazine—CALM1—exocrine gland—esophageal cancer	0.00408	0.0272	CbGeAlD
Chlorpromazine—SMPD1—digestive system—esophageal cancer	0.00373	0.0249	CbGeAlD
Chlorpromazine—SMPD1—lung—esophageal cancer	0.00311	0.0208	CbGeAlD
Chlorpromazine—ABCB11—digestive system—esophageal cancer	0.00295	0.0197	CbGeAlD
Chlorpromazine—Megacolon—Methotrexate—esophageal cancer	0.00292	0.0764	CcSEcCtD
Chlorpromazine—CALM2—neck—esophageal cancer	0.00262	0.0175	CbGeAlD
Chlorpromazine—CALM1—neck—esophageal cancer	0.00261	0.0174	CbGeAlD
Chlorpromazine—HTR7—neck—esophageal cancer	0.00255	0.017	CbGeAlD
Chlorpromazine—CALM3—bronchus—esophageal cancer	0.00224	0.0149	CbGeAlD
Chlorpromazine—CALM3—smooth muscle tissue—esophageal cancer	0.00219	0.0146	CbGeAlD
Chlorpromazine—SMPD1—lymph node—esophageal cancer	0.00213	0.0142	CbGeAlD
Chlorpromazine—CALM3—trachea—esophageal cancer	0.00201	0.0134	CbGeAlD
Chlorpromazine—HTR2B—smooth muscle tissue—esophageal cancer	0.00195	0.013	CbGeAlD
Chlorpromazine—Pigmentation disorder—Capecitabine—esophageal cancer	0.00193	0.0505	CcSEcCtD
Chlorpromazine—CHRM1—trachea—esophageal cancer	0.0018	0.012	CbGeAlD
Chlorpromazine—CALM2—epithelium—esophageal cancer	0.00178	0.0119	CbGeAlD
Chlorpromazine—CALM1—epithelium—esophageal cancer	0.00177	0.0118	CbGeAlD
Chlorpromazine—CALM2—bronchus—esophageal cancer	0.00176	0.0117	CbGeAlD
Chlorpromazine—CHRM3—smooth muscle tissue—esophageal cancer	0.00176	0.0117	CbGeAlD
Chlorpromazine—CALM1—bronchus—esophageal cancer	0.00175	0.0117	CbGeAlD
Chlorpromazine—HTR7—epithelium—esophageal cancer	0.00173	0.0116	CbGeAlD
Chlorpromazine—CALM2—smooth muscle tissue—esophageal cancer	0.00172	0.0115	CbGeAlD
Chlorpromazine—CALM1—smooth muscle tissue—esophageal cancer	0.00171	0.0114	CbGeAlD
Chlorpromazine—ADRA1A—epithelium—esophageal cancer	0.00167	0.0112	CbGeAlD
Chlorpromazine—HTR7—smooth muscle tissue—esophageal cancer	0.00167	0.0112	CbGeAlD
Chlorpromazine—HTR2A—neck—esophageal cancer	0.00159	0.0106	CbGeAlD
Chlorpromazine—CALM2—trachea—esophageal cancer	0.00158	0.0105	CbGeAlD
Chlorpromazine—CALM1—trachea—esophageal cancer	0.00157	0.0105	CbGeAlD
Chlorpromazine—HTR2B—digestive system—esophageal cancer	0.00154	0.0103	CbGeAlD
Chlorpromazine—HTR7—trachea—esophageal cancer	0.00153	0.0102	CbGeAlD
Chlorpromazine—Ileus paralytic—Capecitabine—esophageal cancer	0.00149	0.039	CcSEcCtD
Chlorpromazine—BCHE—bronchus—esophageal cancer	0.00146	0.00977	CbGeAlD
Chlorpromazine—CALM3—lung—esophageal cancer	0.00144	0.00963	CbGeAlD
Chlorpromazine—BCHE—smooth muscle tissue—esophageal cancer	0.00143	0.00956	CbGeAlD
Chlorpromazine—CHRM3—digestive system—esophageal cancer	0.00139	0.00925	CbGeAlD
Chlorpromazine—CALM2—digestive system—esophageal cancer	0.00136	0.00905	CbGeAlD
Chlorpromazine—CALM1—digestive system—esophageal cancer	0.00135	0.00901	CbGeAlD
Chlorpromazine—Retinal disorder—Methotrexate—esophageal cancer	0.00134	0.0351	CcSEcCtD
Chlorpromazine—HTR7—digestive system—esophageal cancer	0.00132	0.0088	CbGeAlD
Chlorpromazine—BCHE—trachea—esophageal cancer	0.00131	0.00878	CbGeAlD
Chlorpromazine—HRH1—epithelium—esophageal cancer	0.00129	0.00864	CbGeAlD
Chlorpromazine—CHRM1—lung—esophageal cancer	0.00129	0.00863	CbGeAlD
Chlorpromazine—HTR2B—lung—esophageal cancer	0.00129	0.00859	CbGeAlD
Chlorpromazine—Sudden death—Capecitabine—esophageal cancer	0.00126	0.0329	CcSEcCtD
Chlorpromazine—ADRA2A—bronchus—esophageal cancer	0.00125	0.00836	CbGeAlD
Chlorpromazine—HRH1—smooth muscle tissue—esophageal cancer	0.00125	0.00833	CbGeAlD
Chlorpromazine—HRH1—trachea—esophageal cancer	0.00114	0.00764	CbGeAlD
Chlorpromazine—CALM2—lung—esophageal cancer	0.00113	0.00756	CbGeAlD
Chlorpromazine—BCHE—digestive system—esophageal cancer	0.00113	0.00755	CbGeAlD
Chlorpromazine—CALM1—lung—esophageal cancer	0.00113	0.00753	CbGeAlD
Chlorpromazine—ADRA2A—trachea—esophageal cancer	0.00112	0.00751	CbGeAlD
Chlorpromazine—HTR7—lung—esophageal cancer	0.0011	0.00735	CbGeAlD
Chlorpromazine—HTR2A—epithelium—esophageal cancer	0.00108	0.00722	CbGeAlD
Chlorpromazine—Infection—Carboplatin—esophageal cancer	0.00106	0.0276	CcSEcCtD
Chlorpromazine—CYP1A2—digestive system—esophageal cancer	0.00105	0.00702	CbGeAlD
Chlorpromazine—HTR2A—smooth muscle tissue—esophageal cancer	0.00104	0.00695	CbGeAlD
Chlorpromazine—DRD2—lung—esophageal cancer	0.00104	0.00695	CbGeAlD
Chlorpromazine—CALM3—lymph node—esophageal cancer	0.000987	0.00659	CbGeAlD
Chlorpromazine—HRH1—digestive system—esophageal cancer	0.000985	0.00657	CbGeAlD
Chlorpromazine—HTR2A—trachea—esophageal cancer	0.000956	0.00638	CbGeAlD
Chlorpromazine—CYP2E1—digestive system—esophageal cancer	0.000946	0.00632	CbGeAlD
Chlorpromazine—BCHE—lung—esophageal cancer	0.000945	0.00631	CbGeAlD
Chlorpromazine—Sudden death—Methotrexate—esophageal cancer	0.000937	0.0245	CcSEcCtD
Chlorpromazine—ALB—lymph node—esophageal cancer	0.000914	0.0061	CbGeAlD
Chlorpromazine—Throat sore—Capecitabine—esophageal cancer	0.000893	0.0234	CcSEcCtD
Chlorpromazine—Oropharyngeal discomfort—Capecitabine—esophageal cancer	0.000885	0.0232	CcSEcCtD
Chlorpromazine—HTR2B—lymph node—esophageal cancer	0.00088	0.00587	CbGeAlD
Chlorpromazine—CYP1A2—lung—esophageal cancer	0.000879	0.00586	CbGeAlD
Chlorpromazine—Body temperature increased—Carboplatin—esophageal cancer	0.00084	0.022	CcSEcCtD
Chlorpromazine—HTR2A—digestive system—esophageal cancer	0.000823	0.00549	CbGeAlD
Chlorpromazine—HRH1—lung—esophageal cancer	0.000823	0.00549	CbGeAlD
Chlorpromazine—ADRA2A—lung—esophageal cancer	0.000808	0.00539	CbGeAlD
Chlorpromazine—CYP2E1—lung—esophageal cancer	0.00079	0.00528	CbGeAlD
Chlorpromazine—CALM2—lymph node—esophageal cancer	0.000775	0.00517	CbGeAlD
Chlorpromazine—CALM1—lymph node—esophageal cancer	0.000771	0.00515	CbGeAlD
Chlorpromazine—CYP3A4—digestive system—esophageal cancer	0.000762	0.00508	CbGeAlD
Chlorpromazine—CYP2D6—digestive system—esophageal cancer	0.000749	0.005	CbGeAlD
Chlorpromazine—ABCB1—epithelium—esophageal cancer	0.000709	0.00473	CbGeAlD
Chlorpromazine—Oropharyngeal pain—Capecitabine—esophageal cancer	0.000708	0.0185	CcSEcCtD
Chlorpromazine—Haemolytic anaemia—Cisplatin—esophageal cancer	0.000702	0.0184	CcSEcCtD
Chlorpromazine—KCNH2—lymph node—esophageal cancer	0.000702	0.00468	CbGeAlD
Chlorpromazine—Nasal congestion—Cisplatin—esophageal cancer	0.000696	0.0182	CcSEcCtD
Chlorpromazine—HTR2A—lung—esophageal cancer	0.000687	0.00459	CbGeAlD
Chlorpromazine—Gait disturbance—Capecitabine—esophageal cancer	0.00066	0.0173	CcSEcCtD
Chlorpromazine—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.000655	0.0171	CcSEcCtD
Chlorpromazine—BCHE—lymph node—esophageal cancer	0.000646	0.00431	CbGeAlD
Chlorpromazine—ABCB1—trachea—esophageal cancer	0.000627	0.00418	CbGeAlD
Chlorpromazine—Orthostatic hypotension—Cisplatin—esophageal cancer	0.000579	0.0152	CcSEcCtD
Chlorpromazine—HRH1—lymph node—esophageal cancer	0.000563	0.00375	CbGeAlD
Chlorpromazine—ADRA2A—lymph node—esophageal cancer	0.000553	0.00369	CbGeAlD
Chlorpromazine—ABCB1—digestive system—esophageal cancer	0.000539	0.0036	CbGeAlD
Chlorpromazine—Photosensitivity—Capecitabine—esophageal cancer	0.000532	0.0139	CcSEcCtD
Chlorpromazine—Pancytopenia—Cisplatin—esophageal cancer	0.00052	0.0136	CcSEcCtD
Chlorpromazine—Haemolytic anaemia—Capecitabine—esophageal cancer	0.000518	0.0135	CcSEcCtD
Chlorpromazine—Dermatitis exfoliative—Capecitabine—esophageal cancer	0.000495	0.013	CcSEcCtD
Chlorpromazine—ABCB1—lung—esophageal cancer	0.00045	0.003	CbGeAlD
Chlorpromazine—Aplastic anaemia—Methotrexate—esophageal cancer	0.00045	0.0118	CcSEcCtD
Chlorpromazine—Cardiac arrest—Capecitabine—esophageal cancer	0.000444	0.0116	CcSEcCtD
Chlorpromazine—Urinary retention—Capecitabine—esophageal cancer	0.000444	0.0116	CcSEcCtD
Chlorpromazine—Gynaecomastia—Methotrexate—esophageal cancer	0.000429	0.0112	CcSEcCtD
Chlorpromazine—Orthostatic hypotension—Capecitabine—esophageal cancer	0.000427	0.0112	CcSEcCtD
Chlorpromazine—Visual impairment—Cisplatin—esophageal cancer	0.000423	0.0111	CcSEcCtD
Chlorpromazine—Influenza—Capecitabine—esophageal cancer	0.000404	0.0106	CcSEcCtD
Chlorpromazine—Dysphagia—Capecitabine—esophageal cancer	0.000404	0.0106	CcSEcCtD
Chlorpromazine—Asthma—Capecitabine—esophageal cancer	0.000404	0.0106	CcSEcCtD
Chlorpromazine—Photosensitivity—Methotrexate—esophageal cancer	0.000396	0.0104	CcSEcCtD
Chlorpromazine—Flurazepam—CYP2A6—esophageal cancer	0.00039	0.146	CrCbGaD
Chlorpromazine—Pancytopenia—Capecitabine—esophageal cancer	0.000384	0.01	CcSEcCtD
Chlorpromazine—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.000369	0.00965	CcSEcCtD
Chlorpromazine—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000369	0.00965	CcSEcCtD
Chlorpromazine—Muscle spasms—Cisplatin—esophageal cancer	0.000367	0.00961	CcSEcCtD
Chlorpromazine—Hyperglycaemia—Capecitabine—esophageal cancer	0.000364	0.00954	CcSEcCtD
Chlorpromazine—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.00036	0.00941	CcSEcCtD
Chlorpromazine—Tremor—Cisplatin—esophageal cancer	0.000358	0.00936	CcSEcCtD
Chlorpromazine—Jaundice—Capecitabine—esophageal cancer	0.000351	0.00919	CcSEcCtD
Chlorpromazine—Leukopenia—Cisplatin—esophageal cancer	0.000342	0.00895	CcSEcCtD
Chlorpromazine—Desipramine—CYP2A6—esophageal cancer	0.000338	0.126	CrCbGaD
Chlorpromazine—Agranulocytosis—Capecitabine—esophageal cancer	0.000336	0.0088	CcSEcCtD
Chlorpromazine—Convulsion—Cisplatin—esophageal cancer	0.000331	0.00866	CcSEcCtD
Chlorpromazine—Oedema peripheral—Capecitabine—esophageal cancer	0.000319	0.00834	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Cisplatin—esophageal cancer	0.000312	0.00816	CcSEcCtD
Chlorpromazine—Visual impairment—Capecitabine—esophageal cancer	0.000312	0.00816	CcSEcCtD
Chlorpromazine—Infection—Cisplatin—esophageal cancer	0.00031	0.0081	CcSEcCtD
Chlorpromazine—ABCB1—lymph node—esophageal cancer	0.000308	0.00206	CbGeAlD
Chlorpromazine—Tachycardia—Cisplatin—esophageal cancer	0.000304	0.00796	CcSEcCtD
Chlorpromazine—Asthma—Methotrexate—esophageal cancer	0.000301	0.00787	CcSEcCtD
Chlorpromazine—Eosinophilia—Methotrexate—esophageal cancer	0.000298	0.00779	CcSEcCtD
Chlorpromazine—Hypotension—Cisplatin—esophageal cancer	0.000291	0.00762	CcSEcCtD
Chlorpromazine—Pancytopenia—Methotrexate—esophageal cancer	0.000286	0.00747	CcSEcCtD
Chlorpromazine—Dyspnoea—Cisplatin—esophageal cancer	0.000278	0.00727	CcSEcCtD
Chlorpromazine—Erectile dysfunction—Methotrexate—esophageal cancer	0.000277	0.00725	CcSEcCtD
Chlorpromazine—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000275	0.00718	CcSEcCtD
Chlorpromazine—Muscle spasms—Capecitabine—esophageal cancer	0.000271	0.00708	CcSEcCtD
Chlorpromazine—Drowsiness—Methotrexate—esophageal cancer	0.000268	0.00702	CcSEcCtD
Chlorpromazine—Tremor—Capecitabine—esophageal cancer	0.000264	0.0069	CcSEcCtD
Chlorpromazine—Syncope—Capecitabine—esophageal cancer	0.000252	0.00661	CcSEcCtD
Chlorpromazine—Leukopenia—Capecitabine—esophageal cancer	0.000252	0.00659	CcSEcCtD
Chlorpromazine—Agranulocytosis—Methotrexate—esophageal cancer	0.00025	0.00655	CcSEcCtD
Chlorpromazine—Diltiazem—ABCB1—esophageal cancer	0.000249	0.0931	CrCbGaD
Chlorpromazine—Loss of consciousness—Capecitabine—esophageal cancer	0.000247	0.00647	CcSEcCtD
Chlorpromazine—Body temperature increased—Cisplatin—esophageal cancer	0.000246	0.00645	CcSEcCtD
Chlorpromazine—Cough—Capecitabine—esophageal cancer	0.000246	0.00643	CcSEcCtD
Chlorpromazine—Dry mouth—Capecitabine—esophageal cancer	0.000234	0.00613	CcSEcCtD
Chlorpromazine—Visual impairment—Methotrexate—esophageal cancer	0.000232	0.00607	CcSEcCtD
Chlorpromazine—Hypersensitivity—Cisplatin—esophageal cancer	0.00023	0.00601	CcSEcCtD
Chlorpromazine—Infection—Capecitabine—esophageal cancer	0.000228	0.00597	CcSEcCtD
Chlorpromazine—Shock—Capecitabine—esophageal cancer	0.000226	0.00591	CcSEcCtD
Chlorpromazine—Tachycardia—Capecitabine—esophageal cancer	0.000224	0.00587	CcSEcCtD
Chlorpromazine—Triflupromazine—ABCB1—esophageal cancer	0.000222	0.083	CrCbGaD
Chlorpromazine—Hypotension—Capecitabine—esophageal cancer	0.000215	0.00562	CcSEcCtD
Chlorpromazine—Insomnia—Capecitabine—esophageal cancer	0.000208	0.00544	CcSEcCtD
Chlorpromazine—Dyspnoea—Capecitabine—esophageal cancer	0.000205	0.00536	CcSEcCtD
Chlorpromazine—Clobazam—ABCB1—esophageal cancer	0.000198	0.0738	CrCbGaD
Chlorpromazine—Constipation—Capecitabine—esophageal cancer	0.000196	0.00514	CcSEcCtD
Chlorpromazine—Leukopenia—Methotrexate—esophageal cancer	0.000188	0.00491	CcSEcCtD
Chlorpromazine—Cough—Methotrexate—esophageal cancer	0.000183	0.00479	CcSEcCtD
Chlorpromazine—Body temperature increased—Capecitabine—esophageal cancer	0.000182	0.00475	CcSEcCtD
Chlorpromazine—Convulsion—Methotrexate—esophageal cancer	0.000182	0.00475	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Methotrexate—esophageal cancer	0.000171	0.00448	CcSEcCtD
Chlorpromazine—Fluphenazine—ABCB1—esophageal cancer	0.000171	0.0638	CrCbGaD
Chlorpromazine—Infection—Methotrexate—esophageal cancer	0.00017	0.00445	CcSEcCtD
Chlorpromazine—Hypersensitivity—Capecitabine—esophageal cancer	0.000169	0.00443	CcSEcCtD
Chlorpromazine—Hypotension—Methotrexate—esophageal cancer	0.00016	0.00418	CcSEcCtD
Chlorpromazine—Clomipramine—ABCB1—esophageal cancer	0.000156	0.0584	CrCbGaD
Chlorpromazine—Chlorprothixene—ABCB1—esophageal cancer	0.000156	0.0581	CrCbGaD
Chlorpromazine—Insomnia—Methotrexate—esophageal cancer	0.000155	0.00405	CcSEcCtD
Chlorpromazine—Dyspnoea—Methotrexate—esophageal cancer	0.000152	0.00399	CcSEcCtD
Chlorpromazine—Somnolence—Methotrexate—esophageal cancer	0.000152	0.00398	CcSEcCtD
Chlorpromazine—Dizziness—Capecitabine—esophageal cancer	0.000152	0.00398	CcSEcCtD
Chlorpromazine—Flurazepam—ABCB1—esophageal cancer	0.000145	0.0543	CrCbGaD
Chlorpromazine—Trimipramine—ABCB1—esophageal cancer	0.000144	0.0537	CrCbGaD
Chlorpromazine—Promethazine—ABCB1—esophageal cancer	0.000138	0.0517	CrCbGaD
Chlorpromazine—Trifluoperazine—ABCB1—esophageal cancer	0.000137	0.051	CrCbGaD
Chlorpromazine—Body temperature increased—Methotrexate—esophageal cancer	0.000135	0.00354	CcSEcCtD
Chlorpromazine—Hypersensitivity—Methotrexate—esophageal cancer	0.000126	0.0033	CcSEcCtD
Chlorpromazine—Desipramine—ABCB1—esophageal cancer	0.000126	0.047	CrCbGaD
Chlorpromazine—Dizziness—Methotrexate—esophageal cancer	0.000113	0.00296	CcSEcCtD
Chlorpromazine—Imipramine—ABCB1—esophageal cancer	0.000107	0.0398	CrCbGaD
Chlorpromazine—CALM3—Immune System—CDKN1A—esophageal cancer	9.2e-06	2.19e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	9.2e-06	2.19e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—EP300—esophageal cancer	9.18e-06	2.19e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—NOTCH1—esophageal cancer	9.17e-06	2.19e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—NOS3—esophageal cancer	9.11e-06	2.17e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—CREBBP—esophageal cancer	9.11e-06	2.17e-05	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—EGFR—esophageal cancer	9.09e-06	2.17e-05	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—EGFR—esophageal cancer	9.08e-06	2.16e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—EP300—esophageal cancer	9.06e-06	2.16e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—ABCB1—esophageal cancer	9e-06	2.14e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—NOS3—esophageal cancer	8.97e-06	2.14e-05	CbGpPWpGaD
Chlorpromazine—CYP2E1—Metabolism—NOS3—esophageal cancer	8.96e-06	2.14e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling by GPCR—EGFR—esophageal cancer	8.95e-06	2.13e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—NOS3—esophageal cancer	8.95e-06	2.13e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Metabolism—PTGS2—esophageal cancer	8.92e-06	2.13e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—NOS3—esophageal cancer	8.92e-06	2.13e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—CDKN1A—esophageal cancer	8.9e-06	2.12e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—CDKN1A—esophageal cancer	8.9e-06	2.12e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Metabolism—NOS3—esophageal cancer	8.9e-06	2.12e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—NOS3—esophageal cancer	8.89e-06	2.12e-05	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—MYC—esophageal cancer	8.89e-06	2.12e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—NOTCH1—esophageal cancer	8.87e-06	2.11e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—NOTCH1—esophageal cancer	8.87e-06	2.11e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—NOS3—esophageal cancer	8.8e-06	2.1e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—NOS3—esophageal cancer	8.78e-06	2.09e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—EP300—esophageal cancer	8.76e-06	2.09e-05	CbGpPWpGaD
Chlorpromazine—SLC22A1—Metabolism—EP300—esophageal cancer	8.75e-06	2.09e-05	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—EGFR—esophageal cancer	8.69e-06	2.07e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling by GPCR—PIK3CA—esophageal cancer	8.68e-06	2.07e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Metabolism—NOS3—esophageal cancer	8.61e-06	2.05e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Metabolism—NOS3—esophageal cancer	8.61e-06	2.05e-05	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—CREBBP—esophageal cancer	8.6e-06	2.05e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—CCND1—esophageal cancer	8.58e-06	2.04e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—GPCR downstream signaling—PIK3CA—esophageal cancer	8.56e-06	2.04e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling by GPCR—PIK3CA—esophageal cancer	8.54e-06	2.04e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—CCND1—esophageal cancer	8.53e-06	2.03e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—ERBB2—esophageal cancer	8.52e-06	2.03e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling by GPCR—PIK3CA—esophageal cancer	8.52e-06	2.03e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—CDKN1A—esophageal cancer	8.5e-06	2.03e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling by GPCR—PIK3CA—esophageal cancer	8.49e-06	2.02e-05	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—MYC—esophageal cancer	8.48e-06	2.02e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—EP300—esophageal cancer	8.47e-06	2.02e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—EP300—esophageal cancer	8.47e-06	2.02e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling by GPCR—PIK3CA—esophageal cancer	8.47e-06	2.02e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—CYP1B1—esophageal cancer	8.43e-06	2.01e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—ERBB2—esophageal cancer	8.39e-06	2e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling by GPCR—PIK3CA—esophageal cancer	8.38e-06	2e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—ERBB2—esophageal cancer	8.37e-06	1.99e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling by GPCR—PIK3CA—esophageal cancer	8.36e-06	1.99e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—ERBB2—esophageal cancer	8.34e-06	1.99e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—ERBB2—esophageal cancer	8.31e-06	1.98e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—CREBBP—esophageal cancer	8.31e-06	1.98e-05	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—EGFR—esophageal cancer	8.3e-06	1.98e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—CDKN1A—esophageal cancer	8.3e-06	1.98e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—CDKN1A—esophageal cancer	8.25e-06	1.97e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—ERBB2—esophageal cancer	8.23e-06	1.96e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—CDKN1A—esophageal cancer	8.22e-06	1.96e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—CDKN1A—esophageal cancer	8.22e-06	1.96e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—ERBB2—esophageal cancer	8.21e-06	1.96e-05	CbGpPWpGaD
Chlorpromazine—CYP2E1—Metabolism—PTGS2—esophageal cancer	8.19e-06	1.95e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling by GPCR—EGFR—esophageal cancer	8.17e-06	1.95e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—CCND1—esophageal cancer	8.17e-06	1.95e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—NOS3—esophageal cancer	8.16e-06	1.94e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Metabolism—PTGS2—esophageal cancer	8.14e-06	1.94e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Metabolism—EP300—esophageal cancer	8.09e-06	1.93e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—EP300—esophageal cancer	8.08e-06	1.93e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—CREBBP—esophageal cancer	8.04e-06	1.92e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—CREBBP—esophageal cancer	8.04e-06	1.92e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—MYC—esophageal cancer	8e-06	1.91e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—CYP19A1—esophageal cancer	7.93e-06	1.89e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling by GPCR—EGFR—esophageal cancer	7.9e-06	1.88e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling by GPCR—EGFR—esophageal cancer	7.9e-06	1.88e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—CDKN1A—esophageal cancer	7.9e-06	1.88e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—EP300—esophageal cancer	7.89e-06	1.88e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—MYC—esophageal cancer	7.89e-06	1.88e-05	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—PIK3CA—esophageal cancer	7.89e-06	1.88e-05	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—PIK3CA—esophageal cancer	7.88e-06	1.88e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Metabolism—PTGS2—esophageal cancer	7.87e-06	1.88e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Metabolism—PTGS2—esophageal cancer	7.87e-06	1.88e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—EP300—esophageal cancer	7.85e-06	1.87e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—EGFR—esophageal cancer	7.82e-06	1.87e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—EP300—esophageal cancer	7.82e-06	1.86e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—EP300—esophageal cancer	7.82e-06	1.86e-05	CbGpPWpGaD
Chlorpromazine—BCHE—Metabolism—PIK3CA—esophageal cancer	7.78e-06	1.85e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling by GPCR—PIK3CA—esophageal cancer	7.77e-06	1.85e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—EGFR—esophageal cancer	7.72e-06	1.84e-05	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—NOS3—esophageal cancer	7.7e-06	1.83e-05	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—TP53—esophageal cancer	7.63e-06	1.82e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—ERBB2—esophageal cancer	7.63e-06	1.82e-05	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—TP53—esophageal cancer	7.62e-06	1.82e-05	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—PIK3CA—esophageal cancer	7.54e-06	1.8e-05	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—CREBBP—esophageal cancer	7.53e-06	1.8e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—CCND1—esophageal cancer	7.53e-06	1.79e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—EP300—esophageal cancer	7.52e-06	1.79e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—EGFR—esophageal cancer	7.46e-06	1.78e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—NOS3—esophageal cancer	7.44e-06	1.77e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Metabolism—EP300—esophageal cancer	7.42e-06	1.77e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—CCND1—esophageal cancer	7.41e-06	1.77e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—CCND1—esophageal cancer	7.39e-06	1.76e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—CCND1—esophageal cancer	7.37e-06	1.76e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—CCND1—esophageal cancer	7.35e-06	1.75e-05	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—TP53—esophageal cancer	7.3e-06	1.74e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—CDKN1A—esophageal cancer	7.28e-06	1.74e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—CCND1—esophageal cancer	7.27e-06	1.73e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—CCND1—esophageal cancer	7.25e-06	1.73e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—HMOX1—esophageal cancer	7.24e-06	1.72e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—EGFR—esophageal cancer	7.22e-06	1.72e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—EGFR—esophageal cancer	7.22e-06	1.72e-05	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—PIK3CA—esophageal cancer	7.2e-06	1.72e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—NOS3—esophageal cancer	7.2e-06	1.72e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—NOS3—esophageal cancer	7.2e-06	1.72e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—CDKN1A—esophageal cancer	7.17e-06	1.71e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—CDKN1A—esophageal cancer	7.15e-06	1.7e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—CDKN1A—esophageal cancer	7.13e-06	1.7e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—CDKN1A—esophageal cancer	7.11e-06	1.69e-05	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—CREBBP—esophageal cancer	7.1e-06	1.69e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling by GPCR—PIK3CA—esophageal cancer	7.09e-06	1.69e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—MYC—esophageal cancer	7.04e-06	1.68e-05	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—PTGS2—esophageal cancer	7.04e-06	1.68e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—CDKN1A—esophageal cancer	7.04e-06	1.68e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—CDKN1A—esophageal cancer	7.02e-06	1.67e-05	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—TP53—esophageal cancer	6.97e-06	1.66e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—ERBB2—esophageal cancer	6.96e-06	1.66e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—ABCB1—esophageal cancer	6.94e-06	1.66e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—EP300—esophageal cancer	6.93e-06	1.65e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—EGFR—esophageal cancer	6.89e-06	1.64e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—MYC—esophageal cancer	6.88e-06	1.64e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling by GPCR—PIK3CA—esophageal cancer	6.86e-06	1.63e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling by GPCR—PIK3CA—esophageal cancer	6.86e-06	1.63e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—MYC—esophageal cancer	6.84e-06	1.63e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—EP300—esophageal cancer	6.82e-06	1.63e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—MYC—esophageal cancer	6.81e-06	1.62e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—MYC—esophageal cancer	6.81e-06	1.62e-05	CbGpPWpGaD
Chlorpromazine—CYP2E1—Metabolism—EP300—esophageal cancer	6.81e-06	1.62e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—EP300—esophageal cancer	6.81e-06	1.62e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	6.8e-06	1.62e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—PIK3CA—esophageal cancer	6.79e-06	1.62e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—EP300—esophageal cancer	6.78e-06	1.62e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Metabolism—EP300—esophageal cancer	6.77e-06	1.61e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—EP300—esophageal cancer	6.76e-06	1.61e-05	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—NOS3—esophageal cancer	6.75e-06	1.61e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—CCND1—esophageal cancer	6.74e-06	1.61e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—ERBB2—esophageal cancer	6.73e-06	1.61e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—ERBB2—esophageal cancer	6.73e-06	1.61e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—EGFR—esophageal cancer	6.73e-06	1.6e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—PIK3CA—esophageal cancer	6.7e-06	1.6e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—EP300—esophageal cancer	6.7e-06	1.6e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—EGFR—esophageal cancer	6.69e-06	1.6e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—EP300—esophageal cancer	6.68e-06	1.59e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—EGFR—esophageal cancer	6.67e-06	1.59e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—EGFR—esophageal cancer	6.67e-06	1.59e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—TP53—esophageal cancer	6.57e-06	1.57e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—MYC—esophageal cancer	6.55e-06	1.56e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Metabolism—EP300—esophageal cancer	6.55e-06	1.56e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Metabolism—EP300—esophageal cancer	6.55e-06	1.56e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—CDKN1A—esophageal cancer	6.52e-06	1.55e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—TP53—esophageal cancer	6.48e-06	1.55e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—PIK3CA—esophageal cancer	6.48e-06	1.54e-05	CbGpPWpGaD
Chlorpromazine—SLC22A1—Metabolism—PIK3CA—esophageal cancer	6.48e-06	1.54e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—EGFR—esophageal cancer	6.41e-06	1.53e-05	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—NOS3—esophageal cancer	6.36e-06	1.52e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—PIK3CA—esophageal cancer	6.27e-06	1.49e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—PIK3CA—esophageal cancer	6.27e-06	1.49e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—EP300—esophageal cancer	6.2e-06	1.48e-05	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—PTGS2—esophageal cancer	6.17e-06	1.47e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—CCND1—esophageal cancer	6.15e-06	1.47e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—MYC—esophageal cancer	6.04e-06	1.44e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—CREBBP—esophageal cancer	6.01e-06	1.43e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Metabolism—PIK3CA—esophageal cancer	5.98e-06	1.43e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—PIK3CA—esophageal cancer	5.98e-06	1.43e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—CDKN1A—esophageal cancer	5.95e-06	1.42e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—CCND1—esophageal cancer	5.95e-06	1.42e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—CCND1—esophageal cancer	5.95e-06	1.42e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—MYC—esophageal cancer	5.94e-06	1.42e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—MYC—esophageal cancer	5.93e-06	1.41e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—MYC—esophageal cancer	5.91e-06	1.41e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—EGFR—esophageal cancer	5.91e-06	1.41e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—MYC—esophageal cancer	5.89e-06	1.4e-05	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—EP300—esophageal cancer	5.86e-06	1.4e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—PIK3CA—esophageal cancer	5.84e-06	1.39e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—MYC—esophageal cancer	5.83e-06	1.39e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—MYC—esophageal cancer	5.82e-06	1.39e-05	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—PTGS2—esophageal cancer	5.81e-06	1.39e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—EGFR—esophageal cancer	5.81e-06	1.39e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—PIK3CA—esophageal cancer	5.81e-06	1.38e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—EGFR—esophageal cancer	5.8e-06	1.38e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—PIK3CA—esophageal cancer	5.78e-06	1.38e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—PIK3CA—esophageal cancer	5.78e-06	1.38e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—EGFR—esophageal cancer	5.78e-06	1.38e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—EGFR—esophageal cancer	5.76e-06	1.37e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—CDKN1A—esophageal cancer	5.76e-06	1.37e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—CDKN1A—esophageal cancer	5.76e-06	1.37e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—EGFR—esophageal cancer	5.71e-06	1.36e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—EGFR—esophageal cancer	5.69e-06	1.36e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—EP300—esophageal cancer	5.66e-06	1.35e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—TP53—esophageal cancer	5.65e-06	1.35e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—TP53—esophageal cancer	5.62e-06	1.34e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—PIK3CA—esophageal cancer	5.56e-06	1.33e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Metabolism—PIK3CA—esophageal cancer	5.49e-06	1.31e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—EP300—esophageal cancer	5.48e-06	1.31e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—EP300—esophageal cancer	5.48e-06	1.31e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—MYC—esophageal cancer	5.41e-06	1.29e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—NOS3—esophageal cancer	5.38e-06	1.28e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—TP53—esophageal cancer	5.38e-06	1.28e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—EGFR—esophageal cancer	5.29e-06	1.26e-05	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—EP300—esophageal cancer	5.13e-06	1.22e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—PIK3CA—esophageal cancer	5.13e-06	1.22e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—PIK3CA—esophageal cancer	5.04e-06	1.2e-05	CbGpPWpGaD
Chlorpromazine—CYP2E1—Metabolism—PIK3CA—esophageal cancer	5.04e-06	1.2e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—PIK3CA—esophageal cancer	5.03e-06	1.2e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—PIK3CA—esophageal cancer	5.02e-06	1.2e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Metabolism—PIK3CA—esophageal cancer	5.01e-06	1.19e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—PIK3CA—esophageal cancer	5e-06	1.19e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—TP53—esophageal cancer	4.96e-06	1.18e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—PIK3CA—esophageal cancer	4.95e-06	1.18e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—PIK3CA—esophageal cancer	4.94e-06	1.18e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—MYC—esophageal cancer	4.93e-06	1.18e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—PTGS2—esophageal cancer	4.92e-06	1.17e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—TP53—esophageal cancer	4.88e-06	1.16e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—TP53—esophageal cancer	4.87e-06	1.16e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—TP53—esophageal cancer	4.85e-06	1.16e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Metabolism—PIK3CA—esophageal cancer	4.84e-06	1.15e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Metabolism—PIK3CA—esophageal cancer	4.84e-06	1.15e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—TP53—esophageal cancer	4.84e-06	1.15e-05	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—EP300—esophageal cancer	4.84e-06	1.15e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—EGFR—esophageal cancer	4.83e-06	1.15e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—TP53—esophageal cancer	4.79e-06	1.14e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—TP53—esophageal cancer	4.78e-06	1.14e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—MYC—esophageal cancer	4.77e-06	1.14e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—MYC—esophageal cancer	4.77e-06	1.14e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—EGFR—esophageal cancer	4.67e-06	1.11e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—EGFR—esophageal cancer	4.67e-06	1.11e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—CREBBP—esophageal cancer	4.64e-06	1.11e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—PIK3CA—esophageal cancer	4.59e-06	1.09e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—TP53—esophageal cancer	4.44e-06	1.06e-05	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—PIK3CA—esophageal cancer	4.33e-06	1.03e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—PIK3CA—esophageal cancer	4.19e-06	9.98e-06	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—NOS3—esophageal cancer	4.16e-06	9.91e-06	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—EP300—esophageal cancer	4.1e-06	9.76e-06	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—TP53—esophageal cancer	4.05e-06	9.66e-06	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—PIK3CA—esophageal cancer	4.05e-06	9.66e-06	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—PIK3CA—esophageal cancer	4.05e-06	9.66e-06	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—TP53—esophageal cancer	3.92e-06	9.34e-06	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—TP53—esophageal cancer	3.92e-06	9.34e-06	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—PTGS2—esophageal cancer	3.8e-06	9.06e-06	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—PIK3CA—esophageal cancer	3.8e-06	9.05e-06	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—PIK3CA—esophageal cancer	3.58e-06	8.53e-06	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—EP300—esophageal cancer	3.16e-06	7.54e-06	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—PIK3CA—esophageal cancer	3.03e-06	7.22e-06	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—PIK3CA—esophageal cancer	2.34e-06	5.57e-06	CbGpPWpGaD
